WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 July 2020 Issue has been Published, Kindly check it on http://www.wjahr.com/home/current_issues

  • WJAHR JULY ISSUE PUBLISHED

    JULY 2020 Issue has been successfully launched on 1 July 2020.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

THE DIFFERENCE IN THYROID HORMONE METABOLISM BETWEEN MAMMALIAN FETUSES AND ADULTS AND ITS IMPLICATIONS

Sing-Yung Wu, M.D., Ph.D.

ABSTRACT

The neonatal screening program for congenital hypothyroidism (CH) implemented nearly half a century ago has helped a lot of neonates with CH. However, judging from the early involvement of thyroid hormone (TH) in brain development, the reliance on the neonatal strategy to reverse 'ALL' of the cerebral and other developmental anomalies may be in question, and there is room for improvement. The study from our group in the past three decades has demonstrated that sulfo-conjugation is the primary pathway for TH metabolism in developing fetuses in utero that is distinctly different from adults. Our studies have also shown that 3,3'-diiodothyronine sulfate (3, 3'-T2S) is a major fetal metabolite in inactivating TH in the developing mammals that do not need the active catabolic hormones. Further, 3, 3'-T2S has been shown to cross the placenta and return to the maternal circulation. The appearance of W-compound, a material detected by3, 3'-T2S-specific antibody in human maternal and fetal circulation has been shown to correlate significantly to fetal thyroid function. It is time to consider a different approach by taking advantage of the difference in TH metabolism between fetuses and adults. Further study on the sulfation pathway may provide an alternative strategy to the current neonatal screening and the "catch-up" therapy after birth.

[Full Text Article]